Hemoglobin Enhances the Binding of Bacterial Endotoxin to Human Endothelial Cells

Summary

Human endothelial cells, when incubated with bacterial endotoxin (lipopolysaccharide, LPS), modify their surface in association with prominent production of procoagulant tissue factor (TF) activity. This deleterious biological effect of LPS has been shown previously to be enhanced approximately 10-fold by the presence of hemoglobin (Hb), a recently recognized LPS binding protein that causes disaggregation of LPS and increases the biological activity of LPS in a number of in vitro assays. The present study was performed to test the hypothesis that Hb enhances the LPS-induced procoagulant activity of human umbilical vein endothelial cells (HUVEC) by increasing LPS binding to the cells. The binding of ³H-LPS to HUVEC was determined in the absence or presence of Hb or two other known LPS-binding proteins, human serum albumin (HSA) and IgG. LPS binding was substantially increased in the presence of Hb, in a Hb concentration-dependent manner, but was not increased by HSA or IgG. Hb enhancement of LPS binding was observed in serum-free medium, indicating that there was no additional requirement for any of the serum factors known to participate in the interaction of LPS with cells (e.g., lipopolysaccharide (LPS)-binding protein (LBP) and soluble CD14 (sCD14)). Hb enhancement of LPS binding also was observed in the more physiologic condition of 100% plasma. LPS-induced TF activity was stimulated by Hb, but not by HSA or IgG. In serum-free medium, TF activity was not stimulated under any of the conditions tested. Ultrafiltration of LPS was dramatically increased after incubation with Hb but not with HSA or IgG, suggesting that LPS disaggregation by Hb was responsible for the enhanced binding of LPS to HUVEC and the subsequent stimulation of TF activity.

• References

• 1 Moore KL, Andreoli SP, Esmon NL, Esmon CT, Bang NU. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest 1987; 79: 124-130
• 2 Colucci M, Balconi G, Lorenzet R, Pietra A, Locati D, Donati MB, Seme-raro N. Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71: 1893-1896
• 3 Roth RI. Hemoglobin enhances the production of tissue factor by endothelial cells in response to bacterial endotoxin. Blood 1994; 83: 2860-2865
• 4 Kaca W, Roth RI, Levin J. Hemoglobin, a newly recognized lipopolysaccharide (LPS)-binding protein that enhances LPS biological activity. J Biol Chem 1994; 269: 25078-25084
• 5 Kaca W, Roth RI, Ziolkowski A, Levin J. Human hemoglobin increases the biological activity of bacterial lipopolysaccharides in activation of Limulus amebocyte lysate and stimulation of tissue factor production by endothelial cells. J Endotoxin Research 1994; 1: 243-252
• 6 Roth RI, Levin J, Chapman KW, Schmeizl M, Rickies FR. Production of modified crosslinked cell-free hemoglobin for human use: the role of quantitative determination of endotoxin contamination. Transfusion 1993; 33: 919-924
• 7 White CT, Murray AJ, Smith DJ, Greene JR, Bolin RB. Synergistic toxicity of endotoxin and hemoglobin. J Lab Clin Med 1986; 108: 132-137
• 8 Winslow RM. Blood substitutes - minireview. In: The Red Cell: Seventh Ann Arbor Conference Brewer GJ. ed. Liss, New York, NY: 1989: 305-323
• 9 Fratantoni JC. (Center for Biologies Evaluation and Research). Points to consider in the safety evaluation of hemoglobin-based oxygen carriers. Transfusion 1991; 31: 369-371
• 10 Wright SD. Multiple receptors for endotoxin. Curr Opin Immunol 1991; 3: 83-90
• 11 Tobias PS, Ulevitch RJ. Lipopolysaccharide-binding protein and CD 14 in the lipopolysaccharide-dependent activation of cells. Chest 1994; 105: 48S-50S
• 12 Osnes LTN, Westvik AB, Ovstebo R, Joo G-B, Okkenhaug C, Kierulf P. Lipopolysaccharide activation of human monocytes mediated by CD 14 results in a coordinated synthesis of tissue factor, TNF-a and IL-6. J Endotoxin Res 1995; 2: 27-35
• 13 Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD 14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990; 249: 1431-1433
• 14 Winslow RM, Chapman KW. Pilot-scale preparation of hemoglobin solutions. Meth Enzymol 1994; 231: 3-16
• 15 Levin J, Bang FB. Clottable protein in Limulus: its localization and kinetics of its coagulation by endotoxin. Thromb Diath Haemorrh 1968; 19: 186-197
• 16 Pugin J, Schurer-Maly C-C, Leturcq D, Moriarty A, Ulevitch RJ, Tobias PS. Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopoly saccharide-binding protein and soluble CD 14. Proc Natl Acad Sci 1993; 90: 2744-2748